Modification of CaCo-2 cell membrane fatty acid composition by eicosapentaenoic acid and palmitic acid: effect on cholesterol metabolism.
Membrane fatty acid composition of CaCo-2 cells was modified by incubating the cells for 8 days in medium containing 100 microM eicosapentaenoic acid or palmitic acid. The effect of membrane fatty acid changes on cholesterol metabolism was then studied. Cells incubated with eicosapentaenoic acid had significant changes in membrane fatty acid composition with an accumulation of 20:5 and 22:5 and a reduction in monoenoic fatty acids compared to cells grown in palmitic acid. Intracellular cholesteryl esters could not be detected in CaCo-2 cells grown in the presence of the n-3 polyunsaturated fatty acid. In contrast, cells incubated with the saturated fatty acid contained 2 micrograms/mg protein of cholesteryl esters. Cells grown in eicosapentaenoic acid, however, accumulated significantly more triglycerides compared to cells modified with palmitic acid. The rate of oleic acid incorporation into triglycerides was significantly increased in cells incubated with eicosapentaenoic acid. CaCo-2 cells modified by eicosapentaenoic acid had lower rates of HMG-CoA reductase and ACAT activities compared to cells modified with palmitic acid. The incorporation of the two fatty acids into cellular lipids also differed. Palmitic acid was predominantly incorporated into cellular triglycerides, whereas eicosapentaenoic acid was preferentially incorporated into phospholipids with 60% of it in the phosphatidylethanolamine fraction. The data indicate that membrane fatty acid composition is significantly altered by growing CaCo-2 cells in eicosapentaenoic acid. These modifications in membrane fatty acid saturation are accompanied by a decrease in the rates of cholesterol synthesis and cholesterol esterification.
Murthy
S
S
Department of Internal Medicine, University of Iowa, Iowa City 52242.
Albright
E
E
Mathur
S N
SN
Field
F J
FJ
D000230:Adenocarcinoma / Q000032:analysis*; D002784:Cholesterol / Q000378:metabolism*; D002788:Cholesterol Esters / Q000032:analysis; D003110:Colonic Neoplasms / Q000032:analysis*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D005227:Fatty Acids / Q000032:analysis*; D006801:Humans; D008563:Membrane Lipids / Q000032:analysis*; D008861:Microsomes / Q000032:analysis; D008871:Microvilli / Q000378:metabolism*; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000494:pharmacology*; D010743:Phospholipids / Q000032:analysis; D014280:Triglycerides / Q000032:analysis; D014407:Tumor Cells, Cultured
D002788:Cholesterol Esters; D005227:Fatty Acids; D008563:Membrane Lipids; D010169:Palmitic Acids; D010743:Phospholipids; D014280:Triglycerides; D019308:Palmitic Acid; D002784:Cholesterol; D015118:Eicosapentaenoic Acid